213
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Chemical characterization of a PD-1/PD-L1 inhibitory activity fraction of the ethanol extract from Gymnadenia conopsea

, , , , , , & show all
Pages 235-249 | Received 22 Aug 2020, Accepted 25 Oct 2020, Published online: 02 Dec 2020
 

Abstract

Searching for PD-1/PD-L1 inhibitor from medicinal plants has become a potential method to discover small molecular cancer immunotherapy drugs. Using PD-1/PD-L1 inhibitory activity assay in vitro, a bioactive fraction was obtained from the ethanol extract of Gymnadenia conopsea. A sensitive UPLC-HRMS/MS method was established for the rapid screening and identification of compositions from bioactive fraction. Based on the characteristic fragmentation patterns of standards analysis and extracted ion chromatogram (EIC) method, 46 compounds were rapidly screened and identified (including 35 succinic acid ester glycosides and 11 other compounds), among which 17 compounds were tentatively identified as new compounds.

Graphical Abstract

Disclosure statement

There are no potential conflicts of interest to declare.

Additional information

Funding

This work financially supported by the grants from the National Natural Sciences Foundation of China (NNSFC; Grant No. 81760783); the Innovation Platform for the Development and Construction of Special Project of Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province (2020-ZJ-Y20) and Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University (SWHX202005); the Scientific Research Common Program of Beijing Municipal Commission of Education (Grant No. KM201911417014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.